Immunotherapy for Osteosarcoma and Ewing sarcoma
|
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Young Investigator Grants |
2007 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
Structure-guided de novo design of molecules that selectively target EWS-FLI1 |
University of Texas Health Science Center at San Antonio / David Libich, PhD |
Innovation Grants |
2023 |
Texas |
Development of New Approaches to Target MAP Kinase Pathway in RAS-driven Rhabdomyosarcoma |
University of Texas Health Science Center at San Antonio / Angelina Vaseva, PhD |
R Accelerated Award Grants |
2023 |
Texas |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
The Meaning of Adolescents' Eating Experiences during Bone Marrow Transplant Recovery.
|
Baylor College of Medicine / Cheryl Rodgers, PhD, RN |
Nurse Researcher Grants |
2007 |
Texas |
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |
The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Jun Yang |
Young Investigator Grants |
2010 |
Tennessee |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |